BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6781999)

  • 1. [Long-term therapy of hypercholesteremia in diabetics with colestipol].
    Düntsch G
    Fortschr Med; 1981 Jan; 99(3):73-5. PubMed ID: 6781999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Colestipol by hypercholesteremia in diabetics].
    Düntsch G
    Fortschr Med; 1977 Jun; 95(22):1492-6. PubMed ID: 873435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocholesterolemic activity of colestipol in diabetes.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):276-84. PubMed ID: 809240
    [No Abstract]   [Full Text] [Related]  

  • 6. Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study.
    Ruoff G
    J Am Geriatr Soc; 1978 Mar; 26(3):121-6. PubMed ID: 624819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adrenocortical functions in hypercholesterolemic patients; effect of long-term treatment with colestipol-HCl (author's transl)].
    Morimoto Y
    Horumon To Rinsho; 1981 Feb; 29(2):237-43. PubMed ID: 7261445
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
    Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
    Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
    Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
    Harvengt C; Desager JP
    Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients.
    Gundersen K; Cooper EE; Ruoff G; Nikolai T; Assenzo JR
    Atherosclerosis; 1976; 25(2-3):303-10. PubMed ID: 795441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
    Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
    Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
    Dorr AE; Gundersen K; Schneider JC; Spencer TW; Martin WB
    J Chronic Dis; 1978 Jan; 31(1):5-14. PubMed ID: 346598
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of colestipol therapy in Type II hyperlipoproteinemia.
    Lees AM; McCluskey MA; Lees RS
    Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
    Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
    Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
    [No Abstract]   [Full Text] [Related]  

  • 18. [Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
    Sauvanet JP; Drouin P; Debry G; Mejean L; Lambert D
    Nouv Presse Med; 1978 May; 7(21):1862. PubMed ID: 673744
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
    Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of hypercholesterolemia with colestipol hydrochloride.
    Ryan JR; Jain AK; McMahon FG
    Clin Pharmacol Ther; 1975 Jan; 17(1):83-7. PubMed ID: 1091391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.